Device type · PCH
Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
PCH
Microbiology
Device class
Class II
FDA decisions since 2015
30
510(k), De Novo and PMA
Adverse event reports
72
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System
- Product code
- PCH
- Device class
- Class II
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3990
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for PCH
Latest FDA decisions
The 8 newest of 30 since 2015.
K262172 · Decided Nov 6, 2026 · 133 days after receipt
Device type: Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System (PCH) · Laboratory Medicine & Pathology
K253722 · Decided May 19, 2026 · 176 days after receipt
Device type: Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System (PCH) · Laboratory Medicine & Pathology
- QIAstat-Dx Gastrointestinal Panel 2; QIAstat-Dx GI Panel 2 Mini B&V; QIAstat-Dx GI Panel 2 Mini B510(k)
K254032 · Decided Mar 9, 2026 · 83 days after receipt
Device type: Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System (PCH) · Laboratory Medicine & Pathology
- Xpert GI Panel510(k)
K251721 · Decided Jan 16, 2026 · 226 days after receipt
Device type: Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System (PCH) · Laboratory Medicine & Pathology
- QIAstat-Dx Gastrointestinal Panel 2; QIAstat-Dx GI Panel 2 Mini B&V; QIAstat-Dx GI Panel 2 Mini B510(k)
K252329 · Decided Oct 22, 2025 · 89 days after receipt
Device type: Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System (PCH) · Laboratory Medicine & Pathology
K251868 · Decided Sep 25, 2025 · 99 days after receipt
Device type: Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System (PCH) · Laboratory Medicine & Pathology
K251993 · Decided Sep 25, 2025 · 90 days after receipt
Device type: Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System (PCH) · Laboratory Medicine & Pathology
K250324 · Decided Feb 28, 2025 · 23 days after receipt
Device type: Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System (PCH) · Laboratory Medicine & Pathology
Reports received
72
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
54
75% of reports
Injury reports
18
25% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 5 | 0 | 0 | 0 |
| Jan 24 | 4 | 0 | 0 | 0 |
| Feb 24 | 2 | 0 | 0 | 0 |
| Mar 24 | 11 | 0 | 0 | 0 |
| Apr 24 | 5 | 0 | 0 | 0 |
| May 24 | 3 | 0 | 0 | 0 |
| Jun 24 | 7 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 2 | 0 | 0 | 0 |
| Sep 24 | 7 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 2 | 0 | 0 | 0 |
| Dec 24 | 2 | 0 | 0 | 0 |
| Jan 25 | 6 | 0 | 0 | 0 |
| Feb 25 | 4 | 4 | 0 | 0 |
| Mar 25 | 1 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 1 | 0 | 0 | 0 |
| Jun 25 | 4 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 4 | 0 | 0 | 0 |
| Sep 25 | 7 | 0 | 1 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 8 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 5 | 0 | 0 | 0 |
| Mar 26 | 4 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 2 | 0 | 0 | 0 |
| Jun 26 | 1 | 0 | 0 | 0 |
| Jul 26 | 19 | 0 | 0 | 0 |
| Aug 26 | 1 | 0 | 0 | 0 |
| Sep 26 | 8 | 2 | 0 | 0 |
| Oct 26 | 6 | 16 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- False Positive Result59
- Incorrect, Inadequate or Imprecise Result or Readings6
- Manufacturing, Packaging or Shipping Problem4
- False Negative Result3
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions72
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- GI Microbiome Profile SmallOpen, Classified
Z-0763-2026 · Started Nov 3, 2025 · Posted by FDA Dec 1, 2025
Reason given: Distribution without premarket approval/clearance.
Cause as FDA categorized it: No Marketing Application
- GI Microbiome Profile XLOpen, Classified
Z-0764-2026 · Started Nov 3, 2025 · Posted by FDA Dec 1, 2025
Reason given: Distribution without premarket approval/clearance.
Cause as FDA categorized it: No Marketing Application
- Mycotoxin Panel TestOpen, Classified
Z-0765-2026 · Started Nov 3, 2025 · Posted by FDA Dec 1, 2025
Reason given: Distribution without premarket approval/clearance.
Cause as FDA categorized it: No Marketing Application
- Intestinal Worms TestOpen, Classified
Z-0785-2026 · Started Nov 3, 2025 · Posted by FDA Dec 1, 2025
Reason given: Distribution without premarket approval/clearance.
Cause as FDA categorized it: No Marketing Application
- Parasite TestOpen, Classified
Z-0793-2026 · Started Nov 3, 2025 · Posted by FDA Dec 1, 2025
Reason given: Distribution without premarket approval/clearance.
Cause as FDA categorized it: No Marketing Application
Z-2514-2024 · Started May 16, 2024 · Posted by FDA Aug 6, 2024
Reason given: Due to increase of false positive Vibrio/Vibrio Cholerae results when using a certain transport medium.
Cause as FDA categorized it: Under Investigation by firm
Z-1140-2024 · Started Jan 26, 2024 · Posted by FDA Feb 15, 2024
Reason given: Due to potential signals of increased false positive Norovirus results when using the gastrointestinal (GI) panel.
Cause as FDA categorized it: Under Investigation by firm
Z-0703-2024 · Started Nov 27, 2023 · Posted by FDA Jan 10, 2024
Reason given: A manufacturing event may contribute to elevated rates of false negative results while using gastrointestinal panel and respiratory panel, which could lead to inappropriate antibiotic treatment, no treatment, delay of treatment, and may provide false assurance to someone with a true infection, delayed identification...
Cause as FDA categorized it: Process control
Showing the 8 newest of 24 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.